These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


106 related items for PubMed ID: 2174522

  • 1. Cholecystokinin antagonists proglumide, lorglumide and benzotript, but not L-364,718, interact with brain opioid binding sites.
    Gaudreau P, Lavigne GJ, Quirion R.
    Neuropeptides; 1990 May; 16(1):51-5. PubMed ID: 2174522
    [Abstract] [Full Text] [Related]

  • 2. Hybrid cholecystokinin-A antagonists based on molecular modeling of lorglumide and L-364,718.
    van der Bent A, Blommaert AG, Melman CT, IJzerman AP, van Wijngaarden I, Soudijn W.
    J Med Chem; 1992 Mar 20; 35(6):1042-9. PubMed ID: 1552499
    [Abstract] [Full Text] [Related]

  • 3. Combined dose-ratio analysis of cholecystokinin receptor antagonists, devazepide, lorglumide and loxiglumide in the guinea-pig gall bladder.
    Bishop LA, Gerskowitch VP, Hull RA, Shankley NP, Black JW.
    Br J Pharmacol; 1992 May 20; 106(1):61-6. PubMed ID: 1504732
    [Abstract] [Full Text] [Related]

  • 4. Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment.
    Kellstein DE, Mayer DJ.
    Brain Res; 1990 May 21; 516(2):263-70. PubMed ID: 2364292
    [Abstract] [Full Text] [Related]

  • 5. Do antagonists of pancreatic cholecystokinin receptors interact with central nervous system cholecystokinin receptors?
    Vigna SR, Szecòwka J, Williams JA.
    Brain Res; 1985 Sep 23; 343(2):394-7. PubMed ID: 2996701
    [Abstract] [Full Text] [Related]

  • 6. Modification by cholecystokinin octapeptide of the binding of mu-, delta-, and kappa-opioid receptors.
    Wang XJ, Han JS.
    J Neurochem; 1990 Oct 23; 55(4):1379-82. PubMed ID: 2168937
    [Abstract] [Full Text] [Related]

  • 7. Spinal co-administration of cholecystokinin antagonists with morphine prevents the development of opioid tolerance.
    Kellstein DE, Mayer DJ.
    Pain; 1991 Nov 23; 47(2):221-229. PubMed ID: 1762818
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Studies of three non-peptide cholecystokinin antagonists (devazepide, lorglumide and loxiglumide) in human isolated alimentary muscle and guinea-pig ileum.
    D'Amato M, Stamford IF, Bennett A.
    Br J Pharmacol; 1991 Feb 23; 102(2):391-5. PubMed ID: 2015421
    [Abstract] [Full Text] [Related]

  • 12. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW, Holladay MW, Barrett RW, Wolfram CA, Miller TR, Witte D, Kerwin JF, Wagenaar F, Nadzan AM.
    Mol Pharmacol; 1989 Dec 23; 36(6):881-6. PubMed ID: 2601685
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Discrete mapping of brain Mu and delta opioid receptors using selective peptides: quantitative autoradiography, species differences and comparison with kappa receptors.
    Sharif NA, Hughes J.
    Peptides; 1989 Dec 23; 10(3):499-522. PubMed ID: 2550910
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists.
    Hahne WF, Jensen RT, Lemp GF, Gardner JD.
    Proc Natl Acad Sci U S A; 1981 Oct 23; 78(10):6304-8. PubMed ID: 6171817
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.